Nihon Kohden (OTCMKTS:NHNKY) Sets New 12-Month Low – Here’s Why

Nihon Kohden Corporation (OTCMKTS:NHNKY)’s share price hit a new 52-week low during trading on Tuesday . The company traded as low as $8.70 and last traded at $8.70, with a volume of 4499 shares. The stock had previously closed at $8.76.

Analyst Upgrades and Downgrades

Separately, Zacks Research upgraded Nihon Kohden to a “hold” rating in a report on Monday, April 27th. One analyst has rated the stock with a Strong Buy rating and one has assigned a Hold rating to the company. According to MarketBeat, the company currently has an average rating of “Buy”.

Nihon Kohden Trading Down 1.9%

The stock has a market capitalization of $1.47 billion, a PE ratio of 14.56 and a beta of 0.40. The business’s 50 day moving average is $9.31 and its 200 day moving average is $10.22.

Nihon Kohden (OTCMKTS:NHNKY) last posted its quarterly earnings data on Thursday, May 14th. The company reported $0.34 earnings per share for the quarter, topping analysts’ consensus estimates of $0.24 by $0.10. The company had revenue of $453.10 million for the quarter, compared to analyst estimates of $414.40 million. Nihon Kohden had a net margin of 6.08% and a return on equity of 9.48%. As a group, analysts anticipate that Nihon Kohden Corporation will post 0.61 EPS for the current year.

Nihon Kohden Company Profile

Nihon Kohden Corporation is a Tokyo-based manufacturer of medical electronic equipment, founded in 1951. The company has built a reputation for innovation in patient monitoring and diagnostic systems, developing one of Japan’s earliest electrocardiogram (ECG) machines and pioneering transistor-based oscilloscopes for clinical use. Over the decades, Nihon Kohden has expanded its product portfolio to address a wide range of healthcare needs, from emergency response to intensive care and neurology.

The company’s core offerings include patient monitors, ECG and electroencephalograph (EEG) devices, defibrillators, infusion pumps, and neuromonitoring systems.